ARTICLE | Company News
Aegera, Pharmascience deal
June 6, 2011 7:00 AM UTC
Generics company Pharmascience acquired cancer company Aegera. Pharmascience said the acquisition will diversify its R&D activities. Aegera's pipeline include AEG35156, a second-generation antisense ...